Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0047 Transporter Info | ||||
Gene Name | ABCA9 | ||||
Transporter Name | ATP-binding cassette sub-family A member 9 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Breast cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in breast cancer | [ 1 ] | |||
Location |
5'UTR (cg19464780) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 3.50E-04; Z-score: 1.80E+00 | ||
Methylation in Case |
6.46E-01 (Median) | Methylation in Control | 5.22E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in breast cancer | [ 1 ] | |||
Location |
TSS1500 (cg01517431) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 8.03E-04; Z-score: -9.81E-01 | ||
Methylation in Case |
4.88E-01 (Median) | Methylation in Control | 5.49E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCA9 in breast cancer | [ 1 ] | |||
Location |
TSS200 (cg22093121) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.79E+00 | Statistic Test | p-value: 4.26E-10; Z-score: 2.01E+00 | ||
Methylation in Case |
1.94E-01 (Median) | Methylation in Control | 1.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCA9 in breast cancer | [ 1 ] | |||
Location |
Body (cg26352073) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.52E-03; Z-score: -8.58E-01 | ||
Methylation in Case |
8.41E-01 (Median) | Methylation in Control | 9.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of ABCA9 in breast cancer | [ 1 ] | |||
Location |
3'UTR (cg12504828) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.46E+00 | Statistic Test | p-value: 1.58E-06; Z-score: -1.58E+00 | ||
Methylation in Case |
5.04E-01 (Median) | Methylation in Control | 7.38E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in colorectal cancer | [ 2 ] | |||
Location |
5'UTR (cg19464780) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.90E-02; Z-score: -6.36E-01 | ||
Methylation in Case |
9.15E-01 (Median) | Methylation in Control | 9.29E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in colorectal cancer | [ 2 ] | |||
Location |
TSS1500 (cg06213598) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 3.71E-06; Z-score: -1.82E+00 | ||
Methylation in Case |
8.57E-01 (Median) | Methylation in Control | 9.09E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCA9 in colorectal cancer | [ 2 ] | |||
Location |
TSS1500 (cg01517431) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 8.31E-05; Z-score: -1.32E+00 | ||
Methylation in Case |
8.10E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCA9 in colorectal cancer | [ 2 ] | |||
Location |
3'UTR (cg12504828) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.10E-03; Z-score: -8.50E-01 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 8.24E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in panic disorder | [ 3 ] | |||
Location |
5'UTR (cg19464780) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 1.67E-03; Z-score: -2.54E-01 | ||
Methylation in Case |
1.36E+00 (Median) | Methylation in Control | 1.47E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in panic disorder | [ 3 ] | |||
Location |
TSS1500 (cg01517431) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 3.79E-03; Z-score: -4.03E-01 | ||
Methylation in Case |
8.20E-01 (Median) | Methylation in Control | 9.93E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg06213598) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 4.79E-09; Z-score: -2.20E+00 | ||
Methylation in Case |
6.22E-01 (Median) | Methylation in Control | 7.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in hepatocellular carcinoma | [ 4 ] | |||
Location |
3'UTR (cg00630480) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 2.19E-12; Z-score: -2.20E+00 | ||
Methylation in Case |
6.35E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in lung adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg01517431) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 2.42E-02; Z-score: -2.30E+00 | ||
Methylation in Case |
6.83E-01 (Median) | Methylation in Control | 7.54E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg19896639) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 2.99E-04; Z-score: -4.89E-01 | ||
Methylation in Case |
6.90E-02 (Median) | Methylation in Control | 9.61E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg10534439) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 4.30E-05; Z-score: -9.65E-01 | ||
Methylation in Case |
1.18E-01 (Median) | Methylation in Control | 1.51E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCA9 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg03851835) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -3.42E+00 | Statistic Test | p-value: 4.85E-13; Z-score: -2.18E+00 | ||
Methylation in Case |
1.56E-01 (Median) | Methylation in Control | 5.34E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of ABCA9 in pancretic ductal adenocarcinoma | [ 6 ] | |||
Location |
Body (cg06845079) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 9.20E-06; Z-score: -1.09E+00 | ||
Methylation in Case |
9.14E-01 (Median) | Methylation in Control | 9.25E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg06213598) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.22E-03; Z-score: 7.56E-01 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS200 (cg22093121) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.97E+00 | Statistic Test | p-value: 9.31E-18; Z-score: 2.66E+00 | ||
Methylation in Case |
2.35E-01 (Median) | Methylation in Control | 1.19E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of ABCA9 in papillary thyroid cancer | [ 7 ] | |||
Location |
3'UTR (cg12504828) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 6.06E-03; Z-score: -5.18E-01 | ||
Methylation in Case |
7.16E-01 (Median) | Methylation in Control | 7.32E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in bladder cancer | [ 8 ] | |||
Location |
TSS200 (cg22093121) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.29E+00 | Statistic Test | p-value: 6.56E-09; Z-score: 8.66E+00 | ||
Methylation in Case |
3.71E-01 (Median) | Methylation in Control | 1.13E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of ABCA9 in bladder cancer | [ 8 ] | |||
Location |
Body (cg26352073) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 2.52E-07; Z-score: -7.10E+00 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of ABCA9 in prostate cancer | [ 9 ] | |||
Location |
Body (cg26829418) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.61E+00 | Statistic Test | p-value: 2.71E-02; Z-score: -4.51E+00 | ||
Methylation in Case |
5.03E-01 (Median) | Methylation in Control | 8.09E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.